Literature DB >> 30264469

Chromosome Missegregation and Aneuploidy Induction in Human Peripheral Blood Lymphocytes In vitro by Low Concentrations of Chlorpyrifos, Imidacloprid and α-Cypermethrin.

Vedran Mužinić1, Snježana Ramić2, Davor Želježić1.   

Abstract

Chlorpyrifos, imidacloprid, and α-cypermethrin are some of the most widely used insecticides in contemporary agriculture. However, their low-dose, nontarget genotoxic effects have not been extensively assayed. As one of the most relevant cancer biomarkers, we aimed to assess the aneuploidy due to chromosome missegregation during mitosis. To aim it we treated human lymphocytes in vitro with three concentrations of insecticides equivalents relevant for real scenario exposure assessed by regulatory agencies. We focused on chlorpyrifos as conventional and imidacloprid and α-cypermethrin as sustainable use insecticides. Cytokinesis-blocked micronucleus assay was performed coupled with fluorescence in situ hybridization (FISH) with directly labeled pancentromeric probes for chromosomes 9, 18, X and Y. None of the insecticides induced significant secondary DNA damage in terms of micronuclei (MN), nuclear buds (NB), or nucleoplasmic bridges (NPB). However, significant disbalances in chromosomes 9, 18, X and Y, and in insecticide-treated cells has been observed. According to recent studies, these disbalances in chromosome numbers may be atributted to defect sister chromatid cohesion which contribute to the increase of chromosome missegregation but not to micronuclei incidence. We conclude that tested insecticidal active substances exert chromosome missegregation effects at low concentrations, possibly by mechanism of sister chromatid cohesion. These findings may contribute to future risk assesments and understanding of insecticide mode of action on human genome. Environ. Mol. Mutagen. 60:72-84, 2019.
© 2018 Wiley Periodicals, Inc. © 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Chlorpyrifos; aneuploidy; fluorescence in situ hybridization; genotoxicity; imidacloprid; α-cypermethrin

Mesh:

Substances:

Year:  2018        PMID: 30264469     DOI: 10.1002/em.22235

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  6 in total

Review 1.  Mosaic loss of human Y chromosome: what, how and why.

Authors:  Xihan Guo; Xueqin Dai; Tao Zhou; Han Wang; Juan Ni; Jinglun Xue; Xu Wang
Journal:  Hum Genet       Date:  2020-02-04       Impact factor: 4.132

2.  Glutathione S-transferase theta genotypes and environmental exposures in the risk of canine transitional cell carcinoma.

Authors:  Katherine R Luethcke; Joanne Ekena; Ruthanne Chun; Lauren A Trepanier
Journal:  J Vet Intern Med       Date:  2019-04-22       Impact factor: 3.333

Review 3.  Insight Into Microbial Applications for the Biodegradation of Pyrethroid Insecticides.

Authors:  Pankaj Bhatt; Yaohua Huang; Hui Zhan; Shaohua Chen
Journal:  Front Microbiol       Date:  2019-08-02       Impact factor: 5.640

4.  Rats exhibit age-related mosaic loss of chromosome Y.

Authors:  Alberto H Orta; Stephen J Bush; Mariana Gutiérrez-Mariscal; Susana Castro-Obregón; Lorraine Jaimes-Hoy; Ricardo Grande; Gloria Vázquez; Elisa Gorostieta-Salas; Mónica Martínez-Pacheco; Karina Díaz-Barba; Paola Cornejo-Páramo; Alejandro Sanchez-Flores; Tamas Székely; Araxi O Urrutia; Diego Cortez
Journal:  Commun Biol       Date:  2021-12-21

5.  The role of ascorbic acid combined exposure on Imidacloprid-induced oxidative stress and genotoxicity in Nile tilapia.

Authors:  Islam M El-Garawani; Elsayed A Khallaf; Alaa A Alne-Na-Ei; Rehab G Elgendy; Gaber A M Mersal; Hesham R El-Seedi
Journal:  Sci Rep       Date:  2021-07-19       Impact factor: 4.379

Review 6.  Environmental exposures associated with elevated risk for autism spectrum disorder may augment the burden of deleterious de novo mutations among probands.

Authors:  Mark A Bellgrove; Ziarih Hawi; Kealan Pugsley; Stephen W Scherer
Journal:  Mol Psychiatry       Date:  2021-05-17       Impact factor: 15.992

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.